🔎︎
The Health Resources and Services Administration announced new cervical cancer screening guidelines that will require most private health insurers to cover at-home Human Papillomavirus testing without patient co-payments or deductibles starting January 1, 2027. The guidelines represent a significant shift in women's preventive care coverage with implications for managed care organizations and health plans.
Under the Public Health Service Act, insurers must cover preventive services listed in HRSA's evidence-based guidelines without patient cost sharing. The new guidelines designate high-risk human papillomavirus testing as the preferred screening method for women ages 30 to 65 at average risk, whether collected by patients themselves or by clinicians. Traditional Pap tests remain a covered option.
The guidelines also state that any additional tests needed to complete cervical cancer screening, such as follow-up cytology, biopsies, colposcopy, or other diagnostic procedures after a positive screening result, must be covered. This comprehensive coverage strategy aims to remove financial barriers that could prevent women from obtaining essential follow-up care.
Approximately three in four American women follow cervical cancer screening recommendations, with higher rates among women with more financial resources or education. More than half of cervical cancer diagnoses occur in women who have either never been screened or are overdue for screening. The self-collection option addresses barriers, including transportation difficulties, scheduling conflicts, and discomfort with traditional screening methods.
The Food and Drug Administration approved several self-collection HPV tests in 2024 and 2025 after research confirmed that patient-collected samples are as effective as clinician-collected samples for detecting cervical cancer and precancerous changes. Depending on the FDA-approved test used, women can collect samples either at their doctor's office or at home and mail the test for processing, similar to at-home colorectal cancer screening.
Health plans will need to establish protocols for test distribution, result reporting, and follow-up care coordination. HRSA added coverage for patient navigation services in 2025 to help women complete screening and follow-up, with that coverage beginning January 1, 2026.
